Zebrafish model of human Zellweger syndrome reveals organ
Zebrafish mannequin of human Zellweger syndrome reveals organ-specific accumulation of distinct fatty acid species and widespread gene expression adjustments
In Zellweger syndrome (ZS), lack of peroxisome perform causes physiological and developmental abnormalities in lots of organs such because the mind, liver, muscle mass, and kidneys, however little is understood in regards to the actual pathogenic mechanism. By disrupting the zebrafish pex2 gene, we established a illness mannequin for ZS and located that it displays pathological options and metabolic adjustments much like these noticed in human sufferers. By complete evaluation of the fatty acid profile, we discovered organ-specific accumulation and discount of distinct fatty acid species, resembling an accumulation of ultra-very-long-chain polyunsaturated fatty acids (ultra-VLC-PUFAs) within the brains of pex2 mutant fish.
Transcriptome evaluation utilizing microarray additionally revealed mutant-specific gene expression adjustments that may result in the signs, together with discount of crystallin, troponin, parvalbumin, and fatty acid metabolic genes. Our information indicated that the lack of peroxisomes ends in widespread metabolic and gene expression adjustments past the causative peroxisomal perform. These outcomes counsel the genetic and metabolic foundation of the pathology of this devastating human illness.
 Human MIG |
|||
| 90216-A | BPS Bioscience | 5 µg | EUR 130 |
|
Description: Recombinant MIG (CXCL9) is a disulfide-linked monomeric protein consisting of 104 amino acid residues, migrates as an approximately 11 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human MIG mature chain was expressed in E. coli. |
|||
Human MIG |
|||
| 90216-B | BPS Bioscience | 20 µg | EUR 205 |
|
Description: Recombinant MIG (CXCL9) is a disulfide-linked monomeric protein consisting of 104 amino acid residues, migrates as an approximately 11 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human MIG mature chain was expressed in E. coli. |
|||
 Anti-Human MIG Antibody |
|||
| 101-M78 | ReliaTech | 500 µg | EUR 246.75 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant murine MIG is a 12.2 kDa protein containing 105 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Anti-Human MIG Antibody |
|||
| 102-P62 | ReliaTech | 100 µg | EUR 245.7 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
) Anti-Human MIG (CXCL9) |
|||
| MBS550702-01mg | MyBiosource | 0.1mg | EUR 260 |
Anti-Human MIG (CXCL9) |
|||
| MBS550702-02mg | MyBiosource | 0.2mg | EUR 335 |
 Mouse Anti-Human MIG |
|||
| MBS690197-05mg | MyBiosource | 0.5mg | EUR 525 |
Mouse Anti-Human MIG |
|||
| MBS690197-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
 Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-006mL | MyBiosource | 0.06mL | EUR 335 |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-012mL | MyBiosource | 0.12mL | EUR 520 |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-02mL | MyBiosource | 0.2mL | EUR 800 |
) Human MIG (CXCL9) |
|||
| MBS691716-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human MIG (CXCL9) |
|||
| MBS691716-002mg | MyBiosource | 0.02mg | EUR 450 |
Human MIG (CXCL9) |
|||
| MBS691716-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
 MIG/CXCL9, Human |
|||
| HY-P7253 | MedChemExpress | 10ug | EUR 321.6 |
 MIG, CXCL9, human |
|||
| RC312-20 | Bio Basic | 5ug | EUR 125.26 |
 Human MIG Recombinant |
|||
| MBS553131-0005mg | MyBiosource | 0.005mg | EUR 165 |
Human MIG Recombinant |
|||
| MBS553131-002mg | MyBiosource | 0.02mg | EUR 245 |
 MIG, human recombinant |
|||
| 4240-1000 | Biovision | each | EUR 5475.6 |
MIG, human recombinant |
|||
| 4240-20 | Biovision | each | EUR 346.8 |
 anti- MIG antibody |
|||
| FNab05188 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against MIG |
|||
 Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-01mg | MyBiosource | 0.1mg | EUR 375 |
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-5x01mg | MyBiosource | 5x0.1mg | EUR 1390 |
 Human MIG ELISA Kit |
|||
| GWB-SKR051 | GenWay Biotech | 96 Tests | Ask for price |
 (Human)) CXCL9 / MIG (74-103) (Human) |
|||
| 045-62 | PHOENIX PEPTIDE | 100 μg | EUR 289.44 |
 (Human)) CXCL9 / MIG (77-103) (Human) |
|||
| 045-63 | PHOENIX PEPTIDE | 100 μg | EUR 257.04 |
 ELISA Kit) MIG (Human) ELISA Kit |
|||
| EKA51867-5x96T | Biomatik Corporation | 5x96T | Ask for price |
MIG (Human) ELISA Kit |
|||
| EKA51867-96T | Biomatik Corporation | 96T | EUR 446.9 |
 ELISA) Human CXCL9 (MIG) ELISA |
|||
| GWB-CXCL9E | GenWay Biotech | 96 well | Ask for price |
) Recombinant Human MIG (CXCL9) |
|||
| 7-02002 | CHI Scientific | 5µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02003 | CHI Scientific | 20µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02004 | CHI Scientific | 1mg | Ask for price |
, (Recombinant)) Human MIG (CXCL9), (Recombinant) |
|||
| 22060423-1 | Bio-WORLD | 5 µg | EUR 190.94 |
Recombinant Human MIG (CXCL9) |
|||
| HECXP-0901 | Cyagen | 5ug | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-002mg | MyBiosource | 0.02mg | EUR 385 |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-1mg | MyBiosource | 1(mg) | EUR 4600 |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-5x1mg | MyBiosource | 5x1mg | EUR 20445 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
 Recombinant Human MIG/CXCL9 |
|||
| P1213-.005 | ApexBio | 5ug | EUR 108.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.1 | ApexBio | 100ug | EUR 900.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.5 | ApexBio | 500ug | EUR 2020.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
) Recombinant Human MIG (CXCL9) |
|||
| Z100665 | ABM | 20 µg | EUR 235 |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Recombinant Human MIG (CXCL9) |
|||
| Z100669 | ABM | 1.0 mg | EUR 3900 |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
 Human Antibody) Anti- Monokine Induced by IFN-gamma (MIG) Human Antibody |
|||
| GWB-B1A431 | GenWay Biotech | 0.1 mg | Ask for price |
) CXCL9 / MIG, recombinant (Human) |
|||
| 033-15 | PHOENIX PEPTIDE | 10 μg | EUR 390.96 |
) Recombinant Human CXCL9 (MIG) |
|||
| 6565 | Immunochemistry | 5 µg | EUR 194 |
 Human) MIG/CXCL9 (Recombinant) Human |
|||
| GWB-4B8A74 | GenWay Biotech | 0.02 mg | Ask for price |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-0005mg | MyBiosource | 0.005mg | EUR 305 |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-5x0005mg | MyBiosource | 5x0.005mg | EUR 1210 |
) MIG Human Recombinant (CXCL9) |
|||
| rAP-0213 | Angio Proteomie | Inquiry | Ask for price |
 Human CXCL9/MIG Antibody Pair Set |
|||
| ABPR-ZB074 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human CXCL9/MIG |
|||
 Anti-Human MIG Rabbit Polyclonal Antibody |
|||
| TA328386 | Origene Technologies GmbH | 100 µg | Ask for price |
) Sheep Polyclonal anti-Human CXCL9 (MIG) |
|||
| hAP-5823 | Angio Proteomie | 50ug | EUR 400 |
) Mouse Monoclonal anti-human CXCL9 (MIG) |
|||
| hAP-0220 | Angio Proteomie | 100ug | EUR 250 |
) InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-01mg | MyBiosource | 0.1mg | EUR 405 |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
 Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.48 | EnoGene | 48T | EUR 295 |
|
Description: 8pg/ml |
|||
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.96 | EnoGene | 96T | EUR 395 |
|
Description: 8pg/ml |
|||
 Human MIG/CXCL9 ELISA Kit |
|||
| E16HE0067 | EnoGene | 96T | EUR 833.33 |
 Human MIG/CXCL9 ELISA KIT |
|||
| E42EH-272 | EnoGene | 96T/48T | EUR 795 |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-48Tests | MyBiosource | 48Tests | EUR 390 |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-5x96Tests | MyBiosource | 5x96Tests | EUR 2275 |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-96Tests | MyBiosource | 96Tests | EUR 495 |
Human MIG/CXCL9 ELISA Kit |
|||
| RK04210 | Abclonal | 96T | EUR 322.37 |
Human MIG/CXCL9 ELISA Kit |
|||
| RK00126 | Abclonal | 96 Tests | EUR 322.37 |
 Human MIG / CXCL9 GENLISA ELISA |
|||
| KBH0049 | Krishgen | 1 x 96 wells | EUR 286 |
 Human CXCL9/MIG ELISA Kit |
|||
| E28L0571 | EnoGene | 96T | EUR 666.67 |
 CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-5x96Tests | MyBiosource | 5x96Tests | EUR 2680 |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-96Tests | MyBiosource | 96Tests | EUR 590 |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-5x96Tests | MyBiosource | 5x96Tests | EUR 2200 |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-96Tests | MyBiosource | 96Tests | EUR 480 |
 LumiAb ELISA Kit) MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-1x96Wells | MyBiosource | 1x96Wells | EUR 520 |
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-5x96Wells | MyBiosource | 5x96Wells | EUR 2395 |
) Recombinant Human MIG (rHuMIG/CXCL9) |
|||
| JOT-PR1091 | Jotbody | 5µg | EUR 205 |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of ＞1 x 104 IU/mg. |
|||
Recombinant Human MIG (rHuMIG/CXCL9) |
|||
| PR1091 | Bioworld Biotech | 5µg | EUR 158 |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of ＞1 x 104 IU/mg. |
|||
 Sandwich ELISA Kit) MIG (Human) Sandwich ELISA Kit |
|||
| OK-0150 | Assay Biotech | 1Kit | EUR 217 |
|
Description: MIG (Human) Colorimetric Sandwich ELISA Kit |
|||
 OmniKine ELISA Kit) MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-1x96Wells | MyBiosource | 1x96Wells | EUR 500 |
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-5x96Wells | MyBiosource | 5x96Wells | EUR 2300 |
 Recombinant Protein) Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072 | ReliaTech | 20 µg | EUR 196.35 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072S | ReliaTech | 5 µg | EUR 92.4 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
 Recombinant Human MIG/CXCL9 protein |
|||
| CD01286-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | EUR 176 |
|
Description: CXCL9 is a T-cell chemoattractant induced by IFN-γ belonging to the CXC chemokine family and it is also known as Monokine induced by gamma interferon (MIG). CXCL9 is closely related to two other CXC chemokines called CXCL10 and CXCL11 and they all elicit their chemotactic functions by interacting with the chemokine receptor CXCR3. CXCL9 is a cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response and chemotactic for activated T-cells. Recombinant human CXCL9 contains 103 amino acids which is a single non-glycosylated polypeptide chain. The human CXCL9 shares 75 % and 67 % a.a. sequence identity with mouse and rat CXCL9. |
|||
 Protein) Recombinant Human MIG (CXCL9) Protein |
|||
| PROTQ07325-2 | BosterBio | 20ug | EUR 380.4 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
 Purified recombinant Human MIG protein |
|||
| MBS5308825-002mg | MyBiosource | 0.02mg | EUR 435 |
Purified recombinant Human MIG protein |
|||
| MBS5308825-5x002mg | MyBiosource | 5x0.02mg | EUR 1905 |
 MIG (CXCL9)) Recombinant Human (E.Coli) MIG (CXCL9) |
|||
| RP-1035 | Alpha Diagnostics | 5 ug | EUR 196.8 |
 Human MIG Recombinant Protein Lyophilized |
|||
| IHUMIGRLY5UG | Innovative research | each | EUR 341 |
|
Description: Human MIG Recombinant Protein Lyophilized |
|||
Human MIG Recombinant Protein Lyophilized |
|||
| MBS8432766-INQUIRE | MyBiosource | INQUIRE | Ask for price |
 Monoclonal antibody, clone MIG-2F5.5) Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535 | Creative Diagnostics | 1 mg; 5 mg | Ask for price |
|
Description: Armenian Hamster |
|||
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
 MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-0005mg | MyBiosource | 0.005mg | EUR 160 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-005mg | MyBiosource | 0.05mg | EUR 290 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-1mg | MyBiosource | 1mg | EUR 2200 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-5x1mg | MyBiosource | 5x1mg | EUR 9755 |
 Human CXCL9/MIG Recombinant Protein |
|||
| PROTQ07325 | BosterBio | Regular: 20ug | EUR 250 |
|
Description: Human CXCL9/MIG Recombinant Protein expressed in E. coli with His-tag. Sequence domain: 23-125aa. Application(s): SDS-PAGE. |
|||
) MIG Human Recombinant Protein (CXCL9) |
|||
| PROTQ07325-1 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: MIG (monokine induced by gamma-interferon ) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 103 amino acids and having a molecular mass of 11700 Dalton. The MIG is purified by proprietary chromatographic techniques. |
|||
 PAb) Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0055 | GenWay Biotech | 1 kit | Ask for price |
 Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-01mg | MyBiosource | 0.1mg | EUR 320 |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-5x01mg | MyBiosource | 5x0.1mg | EUR 1390 |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| TA354753 | Origene Technologies GmbH | 100 µg | Ask for price |
 His Tag) Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-1mg | MyBiosource | 1mg | EUR 3815 |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-5x1mg | MyBiosource | 5x1mg | EUR 16840 |
) Recombinant Human MIG protein (C-6His) |
|||
| CD01287-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 275 |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 823 |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
) OKAG00051-96W - MIG ELISA Kit (Human) |
|||
| OKAG00051-96W | Aviva Systems Biology | 1plate:12x8-WellMicrostrips | EUR 500 |
) OKRC00714-96W - MIG ELISA Kit (Human) |
|||
| OKRC00714-96W | Aviva Systems Biology | 96Wells | EUR 525 |
, His Tag) MIG Human Recombinant (CXCL9), His Tag |
|||
| rAP-0212 | Angio Proteomie | Inquiry | Ask for price |
 - ELISA Kit) CXCL9 / MIG, recombinant (Human) - ELISA Kit |
|||
| EK-033-15 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
 MIG antibody |
|||
| 10R-M169A | Fitzgerald | 500 ug | EUR 240 |
|
Description: Mouse monoclonal MIG antibody |
|||
MIG antibody |
|||
| 70R-MR007 | Fitzgerald | 50 ug | EUR 400 |
|
Description: Affinity purified Rabbit polyclonal MIG antibody |
|||
 MIG Antibody |
|||
| C30114-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG Antibody |
|||
| C30114-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG antibody |
|||
| MBS532154-05mg | MyBiosource | 0.5mg | EUR 370 |
MIG antibody |
|||
| MBS532154-5x05mg | MyBiosource | 5x0.5mg | EUR 1525 |
MIG antibody |
|||
| MBS534409-005mg | MyBiosource | 0.05mg | EUR 465 |
MIG antibody |
|||
| MBS534409-01mg | MyBiosource | 0.1mg | EUR 575 |
MIG antibody |
|||
| MBS534409-5x01mg | MyBiosource | 5x0.1mg | EUR 2430 |
 MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-15Plates | MyBiosource | 15Plates | EUR 600 |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5Plates | MyBiosource | 5Plates | EUR 345 |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5x15Plates | MyBiosource | 5x15Plates | EUR 2755 |
 mig-22 Antibody |
|||
| CSB-PA005373XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-22 protein |
|||
mig-22 Antibody |
|||
| CSB-PA005373XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-22 protein |
|||
 mig-21 Antibody |
|||
| CSB-PA242793XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-21 protein |
|||
mig-21 Antibody |
|||
| CSB-PA242793XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-21 protein |
|||
 mig-14 Antibody |
|||
| CSB-PA296000XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-14 protein |
|||
mig-14 Antibody |
|||
| CSB-PA296000XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-14 protein |
|||
 mig-10 Antibody |
|||
| CSB-PA327322XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-10 protein |
|||
mig-10 Antibody |
|||
| CSB-PA327322XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-10 protein |
|||
 mig-17 Antibody |
|||
| CSB-PA631334XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-17 protein |
|||
mig-17 Antibody |
|||
| CSB-PA631334XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-17 protein |
|||
 mig-23 Antibody |
|||
| CSB-PA637437XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-23 protein |
|||
mig-23 Antibody |
|||
| CSB-PA637437XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-23 protein |
|||
 mig-15 Antibody |
|||
| CSB-PA637566XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-15 protein |
|||
mig-15 Antibody |
|||
| CSB-PA637566XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-15 protein |
|||
 mig-39 Antibody |
|||
| CSB-PA341530XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-39 protein |
|||
mig-39 Antibody |
|||
| CSB-PA341530XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-39 protein |
|||
 mig-13 Antibody |
|||
| CSB-PA794243XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-13 protein |
|||
mig-13 Antibody |
|||
| CSB-PA794243XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-13 protein |
|||
 mig-18 Antibody |
|||
| CSB-PA210991XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-18 protein |
|||
mig-18 Antibody |
|||
| CSB-PA210991XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-18 protein |
|||
 mig-38 Antibody |
|||
| CSB-PA898913XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-38 protein |
|||
mig-38 Antibody |
|||
| CSB-PA898913XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-38 protein |
|||
 MIG |
|||
| chm-333 | ProSpec Tany | 5µg | EUR 60 |
|
Description: Recombinant Human MIG (CXCL9) |
|||
) Anti-CXCL9/MIG Antibody (aa23-125) |
|||
| MBS2401492-01mL | MyBiosource | 0.1mL | EUR 595 |
Anti-CXCL9/MIG Antibody (aa23-125) |
|||
| MBS2401492-5x01mL | MyBiosource | 5x0.1mL | EUR 2500 |
 Nori® Human CXCL9/MIG ELISA Kit |
|||
| GR106310 | Genorise Scientific | 96-well | EUR 461 |
 mig-5 Antibody |
|||
| CSB-PA437276XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-5 protein |
|||
mig-5 Antibody |
|||
| CSB-PA437276XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-5 protein |
|||
 mig-6 Antibody |
|||
| CSB-PA017431XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-6 protein |
|||
mig-6 Antibody |
|||
| CSB-PA017431XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-6 protein |
|||
) Recombinant Human MIG-C4 protein (C-6His) |
|||
| CD01285-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 188 |
|
Description: Recombinant Human Ly6/PLAUR Domain-Containing Protein 3 is produced by our Mammalian expression system and the target gene encoding Leu31-His286 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG-C4 protein (C-6His) |
|||
| CD01285-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 517 |
|
Description: Recombinant Human Ly6/PLAUR Domain-Containing Protein 3 is produced by our Mammalian expression system and the target gene encoding Leu31-His286 is expressed with a 6His tag at the C-terminus. |
|||
 : 96 Wells (OKAG00051)) MIG ELISA Kit (Human) : 96 Wells (OKAG00051) |
|||
| OKAG00051 | Aviva Systems Biology | 96 Wells | EUR 715.2 |
|
Description: Description of target: This antimicrobial gene encodes a protein thought to be involved in T cell trafficking. The encoded protein binds to C-X-C motif chemokine 3 and is a chemoattractant for lymphocytes but not for neutrophils.;Species reactivity: Human;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 16 pg/mL |
|||
 PAb) Biotinylated Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0059 | GenWay Biotech | 1 kit | Ask for price |
 (NM_002416) Human Over-expression Lysate) MIG (CXCL9) (NM_002416) Human Over-expression Lysate |
|||
| E45H06179-2 | EnoGene | each | EUR 395 |
MIG (CXCL9) (NM_002416) Human Over-expression Lysate |
|||
| LS004283 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of chemokine (C-X-C motif) ligand 9 (CXCL9) |
|||
 Recombinant Human CXCL9/MIG Protein, His Tag |
|||
| E40KMH960 | EnoGene | 20ug | EUR 495 |
 - I-125 Labeled) CXCL9 / MIG, recombinant (Human) - I-125 Labeled |
|||
| T-033-15 | PHOENIX PEPTIDE | 10 μCi | EUR 1145.88 |
 Antibody) Mig-7 (MIG7) Antibody |
|||
| abx339505-100l | Abbexa | 100 µl | EUR 350 |
Mig-7 (MIG7) Antibody |
|||
| 20-abx339505 | Abbexa |
|
|
Mig-7 (MIG7) Antibody |
|||
| abx339505-50l | Abbexa | 50 µl | EUR 250 |
Genomic choice and genetic achieve for nut yield in an Australian macadamia breeding inhabitants
Background: Enhancing yield prediction and choice effectivity is important for tree breeding. That is very important for macadamia bushes with the time from crossing to manufacturing of recent cultivars being nearly 1 / 4 of a century. Genomic choice (GS) is a great tool in plant breeding, significantly with perennial bushes, contributing to an elevated fee of genetic achieve and lowering the size of the breeding cycle. We investigated the potential of utilizing GS strategies to extend genetic achieve and speed up choice effectivity within the Australian macadamia breeding program with comparability to conventional breeding strategies. This research evaluated the prediction accuracy of GS in a macadamia breeding inhabitants of 295 full-sib progeny from 32 households (29 dad and mom, reciprocals mixed), together with a subset of oldsters. Historic yield information for tree ages 5 to eight years had been used within the research, together with a set of 4113 SNP markers. The traits of focus had been common nut yield from tree ages 5 to eight years and yield stability, measured as the usual deviation of yield over these Four years. GBLUP GS fashions had been used to acquire genomic estimated breeding values for every genotype, with a five-fold cross-validation methodology and two methods: prediction throughout associated populations and prediction throughout unrelated populations.
Outcomes: Slim-sense heritability of yield and yield stability was low (h2 = 0.30 and 0.04, respectively). Prediction accuracy for yield was 0.57 for predictions throughout associated populations and 0.14 when predicted throughout unrelated populations. Accuracy of prediction of yield stability was excessive (r = 0.79) for predictions throughout associated populations. Predicted genetic achieve of yield utilizing GS in associated populations was 474 g/yr, greater than double that of conventional breeding strategies (226 g/yr), as a result of halving of technology size from Eight to Four years.
Conclusions: The outcomes of this research point out that the incorporation of GS for yield into the Australian macadamia breeding program might speed up genetic achieve as a result of discount in technology size, although the price of genotyping seems to be a constraint at current.
Comparability of the Knowledge of a Subsequent-Era Sequencing Panel from Okay-MASTER Challenge with that of Orthogonal Strategies for Detecting Targetable Genetic Alterations
Objective: Okay-MASTER venture is a Korean nationwide precision drugs platform that screened actionable mutations by analyzing next-generation sequencing (NGS) of strong tumor sufferers. We in contrast gene analyses between NGS panel from the Okay-MASTER venture and orthogonal strategies.
Supplies and strategies: Colorectal, breast, non-small-cell lung, and gastric most cancers sufferers had been included. We in contrast NGS outcomes from Okay-MASTER tasks with these of non-NGS orthogonal strategies (KRAS, NRAS, and BRAF mutations in colorectal most cancers (CRC); EGFR, ALK fusion, and ROS1 fusion in non-small-cell lung most cancers (NSCLC), and ERBB2 positivity in breast and gastric cancers).
Outcomes: Within the CRC cohort (n=225), the sensitivity and specificity of NGS had been 87.4% and 79.3% (KRAS); 88.9% and 98.9% (NRAS); and 77.8% and 100.0% (BRAF), respectively. Within the NSCLC cohort (n=109), the sensitivity and specificity of NGS for EGFR had been 86.2% and 97.5%, respectively. The concordance fee for ALK fusion was 100%, however ROS1 fusion was optimistic in solely certainly one of three instances that had been optimistic in orthogonal checks. Within the breast most cancers cohort (n=260), ERBB2 amplification was detected in 45 by NGS. In contrast with orthogonal strategies that built-in immunohistochemistry and in situ hybridization, sensitivity and specificity had been 53.7% and 99.4%, respectively. Within the gastric most cancers cohort (n=64), ERBB2 amplification was detected in six by NGS. In contrast with orthogonal strategies, sensitivity and specificity had been 62.5% and 98.2%, respectively.
Conclusion: The outcomes of the Okay-MASTER NGS panel and orthogonal strategies confirmed a distinct diploma of settlement for every genetic alteration, however typically confirmed a excessive settlement fee.
Nicotinamide N-Methyltransferase Gene Silencing Enhances Chemosensitivity of Melanoma Cell Strains
Melanoma accounts for much less than 5% of all cutaneous neoplasms however is answerable for the better a part of pores and skin cancer-related deaths. Subsequently, the identification of molecules that might function therapeutic goal is pressing. This research targeted on the enzyme nicotinamide N-methyltransferase (NNMT). The impact of NNMT knockdown on cell proliferation and migration of A375 melanoma cells was evaluated by MTT and wound therapeutic assays, respectively. Viability of A375 cells downregulating NNMT was additionally explored beneath therapy with dacarbazine, a chemotherapeutic drug accepted for superior melanoma therapy. The affect of enzyme knockdown on cell proliferation and chemosensitivity was additionally investigated in WM-115 melanoma cells.
Outcomes obtained demonstrated that NNMT silencing led to a major discount of cell proliferation and migration of A375 cells. Furthermore, enzyme downregulation was related to a rise of melanoma cells sensitivity to therapy with dacarbazine. Analogous results induced by enzyme knockdown on cell proliferation and chemosensitivity had been additionally present in WM-115 cell line. Our information appear to reveal that NNMT might signify a promising molecular goal for the efficient therapy of this type of pores and skin most cancers.
 Mouse anti Human CD40L/CD154/TNFSF5 Monoclonal Antibody |
|||
| MBS2543299-006mL | MyBiosource | 0.06mL | EUR 250 |
Mouse anti Human CD40L/CD154/TNFSF5 Monoclonal Antibody |
|||
| MBS2543299-012mL | MyBiosource | 0.12mL | EUR 370 |
Mouse anti Human CD40L/CD154/TNFSF5 Monoclonal Antibody |
|||
| MBS2543299-02mL | MyBiosource | 0.2mL | EUR 550 |
 Recombinant Human TNFSF5 protein |
|||
| CD00789-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 118 |
|
Description: Recombinant Human CD40 Ligand is produced by our E.coli expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
Recombinant Human TNFSF5 protein |
|||
| CD00789-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 329 |
|
Description: Recombinant Human CD40 Ligand is produced by our E.coli expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
Recombinant Human TNFSF5 protein |
|||
| CD00790-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 223 |
|
Description: Recombinant Human CD40 Ligand is produced by our Mammalian expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
Recombinant Human TNFSF5 protein |
|||
| CD00790-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 588 |
|
Description: Recombinant Human CD40 Ligand is produced by our Mammalian expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
 Antibody) Anti-Human TNFSF5 (CD40 Ligand) Antibody |
|||
| 101-M849 | ReliaTech | 100 µg | EUR 399 |
|
Description: CD40 ligand (CD40L), also known as CD154, TNFSF5, TRAP or gp39, is a 260 amino acid type II transmembrane glycoprotein belonging to the TNF family. Murine CD40L consists of a 22 aa cytoplasmic domain, a 24 aa transmembrane domain, and 214 aa extracellular domain bearing a single glycosylation site. CD40L is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including NK cells, mast cells, basophils and eosinophils. Murine CD40L shares 78% amino acid sequence identity with human CD40L. Native bioactive soluble CD40L exists. Soluble human trimeric CD40L secreted by stimulated T cells has been shown to be generated by proteolysis in the microsomes. Both membrane bound and soluble CD40L induce similar effects on B cells. |
|||
 Anti-Human CD154/CD40LG/TNFSF5 Nanobody |
|||
| MBS1568075-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CD154/CD40LG/TNFSF5 Nanobody |
|||
| MBS1568075-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
 Human sCD40L/ TNFSF5 ELISA KIT |
|||
| E42EH-225 | EnoGene | 96T/48T | EUR 795 |
) Anti-Human CD154/CD40LG/TNFSF5 Antibody (5C8) |
|||
| MBS1564348-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CD154/CD40LG/TNFSF5 Antibody (5C8) |
|||
| MBS1564348-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
 TNFSF5 Antibody |
|||
| GWB-4527AE | GenWay Biotech | 0.025 mg | Ask for price |
) Anti-Human CD154/CD40LG/TNFSF5 Antibody (hu5c8) |
|||
| MBS1564347-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CD154/CD40LG/TNFSF5 Antibody (hu5c8) |
|||
| MBS1564347-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
) Mouse Monoclonal anti-human TNFSF5 (CD40 Ligand) |
|||
| hAP-0173 | Angio Proteomie | 100ug | EUR 250 |
Mouse Monoclonal anti-human TNFSF5 (CD40 Ligand) |
|||
| hAP-0173A | Angio Proteomie | 100ug | EUR 250 |
) Sheep Polyclonal anti-Human TNFSF5 (CD40 Ligand) |
|||
| hAP-5652 | Angio Proteomie | 50ug | EUR 400 |
 Recombinant Human TNFSF5/CD40 Ligand Protein |
|||
| RP01082 | Abclonal | 10 μg | EUR 205.47 |
 Human CellExp? CD40 Ligand / TNFSF5, Human Recombinant |
|||
| P1174-10 | Biovision | each | EUR 196.8 |
Human CellExp? CD40 Ligand / TNFSF5, Human Recombinant |
|||
| P1174-50 | Biovision | each | EUR 666 |
 Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-50ug | Novoprotein | 50ug | EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| AP76030 | SAB | 1mg | EUR 3209 |
 Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-001mg | MyBiosource | 0.01mg | EUR 265 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-002mg | MyBiosource | 0.02mg | EUR 360 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-005mg | MyBiosource | 0.05mg | EUR 450 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-01mg | MyBiosource | 0.1mg | EUR 670 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-025mg | MyBiosource | 0.25mg | EUR 1075 |
 Recombinant Human CD40L/CD154/TNFSF5 Protein |
|||
| MBS2557334-002mg | MyBiosource | 0.02mg | EUR 270 |
Recombinant Human CD40L/CD154/TNFSF5 Protein |
|||
| MBS2557334-01mg | MyBiosource | 0.1mg | EUR 690 |
Recombinant Human CD40L/CD154/TNFSF5 Protein |
|||
| MBS2557334-5x01mg | MyBiosource | 5x0.1mg | EUR 3105 |
 Human CD40 Ligand/TNFSF5 Recombinant Protein |
|||
| PROTP29965 | BosterBio | Regular: 50ug | EUR 250 |
|
Description: Human CD40 Ligand/TNFSF5 Recombinant Protein expressed in E. coli with His-tag. Sequence domain: 113-261aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
|||
 Recombinant Human TNFSF5/CD40 ligand/CD154 Protein |
|||
| RP01733 | Abclonal | 20μg | EUR 74.39 |
 Recombinant Human TNFSF5/CD40 Ligand Trimer Protein |
|||
| RP02040 | Abclonal | 100μg | EUR 325.91 |
Recombinant Human TNFSF5/CD40 Ligand Trimer Protein |
|||
| RP02053 | Abclonal | 100μg | EUR 325.91 |
) Recombinant Human CD40L/TNFSF5 Protein (His Tag) |
|||
| PKSH033726-10ug | Elabscience Biotech | 10ug | EUR 92 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (His Tag) |
|||
| PKSH033726-50ug | Elabscience Biotech | 50ug | EUR 214 |
|
Description: Human |
|||
(Active)) Recombinant Human CD40L/TNFSF5 Protein (Human Cells)(Active) |
|||
| PKSH032214-10ug | Elabscience Biotech | 10ug | EUR 117 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (Human Cells)(Active) |
|||
| PKSH032214-50ug | Elabscience Biotech | 50ug | EUR 297 |
|
Description: Human |
|||
 Recombinant Human CD40 Ligand/CD40L/TNFSF5 Protein |
|||
| MBS2552473-001mg | MyBiosource | 0.01mg | EUR 170 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 Protein |
|||
| MBS2552473-005mg | MyBiosource | 0.05mg | EUR 305 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 Protein |
|||
| MBS2552473-5x005mg | MyBiosource | 5x0.05mg | EUR 1365 |
(Active)) Recombinant Human CD40L/TNFSF5 Protein (E.coli)(Active) |
|||
| PKSH033725-100ug | Elabscience Biotech | 100ug | EUR 739 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (E.coli)(Active) |
|||
| PKSH033725-20ug | Elabscience Biotech | 20ug | EUR 249 |
|
Description: Human |
|||
 Human CellExp? CD40 Ligand / TNFSF5, Fc tag, Human Recombinant |
|||
| P1175-10 | Biovision | each | EUR 196.8 |
Human CellExp? CD40 Ligand / TNFSF5, Fc tag, Human Recombinant |
|||
| P1175-50 | Biovision | each | EUR 666 |
) Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| AP74776 | SAB | 1mg | EUR 1369 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-10ug | Novoprotein | 10ug | EUR 120 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-1mg | Novoprotein | 1mg | EUR 1131.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-500ug | Novoprotein | 500ug | EUR 808.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-50ug | Novoprotein | 50ug | EUR 230.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
) Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| MBS2569051-001mg | MyBiosource | 0.01mg | EUR 165 |
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| MBS2569051-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| MBS2569051-5x005mg | MyBiosource | 5x0.05mg | EUR 1430 |
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| PKSH033868-10ug | Elabscience Biotech | 10ug | EUR 104 |
|
Description: Human |
|||
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| PKSH033868-50ug | Elabscience Biotech | 50ug | EUR 312 |
|
Description: Human |
|||
) Recombinant Human CD40L/CD154/TNFSF5/Protein (His Tag) |
|||
| MBS2552272-01mg | MyBiosource | 0.1mg | EUR 630 |
Recombinant Human CD40L/CD154/TNFSF5/Protein (His Tag) |
|||
| MBS2552272-1mg | MyBiosource | 1(mg) | EUR 4115 |
Recombinant Human CD40L/CD154/TNFSF5/Protein (His Tag) |
|||
| MBS2552272-5x1mg | MyBiosource | 5x1mg | EUR 18515 |
) Recombinant Human CD40L/CD154/TNFSF5 Protein (N-His) |
|||
| MBS2557335-001mg | MyBiosource | 0.01mg | EUR 155 |
Recombinant Human CD40L/CD154/TNFSF5 Protein (N-His) |
|||
| MBS2557335-005mg | MyBiosource | 0.05mg | EUR 240 |
Recombinant Human CD40L/CD154/TNFSF5 Protein (N-His) |
|||
| MBS2557335-5x005mg | MyBiosource | 5x0.05mg | EUR 1080 |
(Active)) Recombinant Human CD40L/TNFSF5 Protein (His Tag)(Active) |
|||
| PKSH031976-100ug | Elabscience Biotech | 100ug | EUR 670 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (His Tag)(Active) |
|||
| PKSH031976-1mg | Elabscience Biotech | 1mg | EUR 4715 |
|
Description: Human |
|||
 CD40 Ligand/TNFSF5 |
|||
| E21-011 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human CD40 Ligand is produced by our E.coli expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
 CD154/CD40L/TNFSF5 |
|||
| E21-I56 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human CD40 Ligand is produced by our Mammalian expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
) TNFSF5 (CD40 Ligand) |
|||
| MBS692711-01mg | MyBiosource | 0.1mg | EUR 725 |
TNFSF5 (CD40 Ligand) |
|||
| MBS692711-5x01mg | MyBiosource | 5x0.1mg | EUR 2965 |
CD40 Ligand/TNFSF5 |
|||
| MBS8532832-001mg | MyBiosource | 0.01mg | EUR 305 |
CD40 Ligand/TNFSF5 |
|||
| MBS8532832-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
CD154/CD40L/TNFSF5 |
|||
| MBS8532979-001mg | MyBiosource | 0.01mg | EUR 305 |
CD154/CD40L/TNFSF5 |
|||
| MBS8532979-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
 Recombinant Human CD40 Ligand/CD154/CD40L/TNFSF5 Protein |
|||
| RP00329 | Abclonal | 10μg | EUR 134.62 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-1mg |
|||
| QP8528-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
) Anti-Mouse CD154/CD40L/TNFSF5 Antibody (MR1/MR-1) |
|||
| MBS1569703-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Mouse CD154/CD40L/TNFSF5 Antibody (MR1/MR-1) |
|||
| MBS1569703-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-10ug |
|||
| QP8528-ec-10ug | EnQuireBio | 10ug | EUR 240 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-50ug |
|||
| QP8528-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-1mg |
|||
| QP9047-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-100ug |
|||
| QP8528-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-200ug |
|||
| QP8528-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-500ug |
|||
| QP8528-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-10ug |
|||
| QP9047-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-50ug |
|||
| QP9047-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-100ug |
|||
| QP9047-ye-100ug | EnQuireBio | 100ug | EUR 576 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-200ug |
|||
| QP9047-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-500ug |
|||
| QP9047-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
 Antibody) CD40LG/TNFSF5 (Cd40 Ligand) Antibody |
|||
| 20-abx111483 | Abbexa |
|
|
 Protein) Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065933-100g | Abbexa | 100 µg | EUR 475 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065933-10g | Abbexa | 10 µg | EUR 200 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065933-50g | Abbexa | 50 µg | EUR 337.5 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065936-100g | Abbexa | 100 µg | EUR 475 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065936-10g | Abbexa | 10 µg | EUR 200 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065936-50g | Abbexa | 50 µg | EUR 337.5 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx168182-1ml | Abbexa | 1 ml | EUR 225 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx670194-50g | Abbexa | 50 µg | EUR 487.5 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-1mg |
|||
| QP5332-1mg | EnQuireBio | 1mg | EUR 1633.2 |
 Human CD40 Ligand/TNFSF5/CD40LG PicoKine® Quick ELISA Kit |
|||
| FEK0573 | BosterBio | 96 wells/kit, with removable strips. | EUR 499 |
|
Description: Human CD40 Ligand/TNFSF5/CD40LG PicoKine® Quick ELISA Kit (90 minutes, 96 Tests). Quantitate Human CD40 Ligand/TNFSF5/CD40LG in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 15 pg/ml. |
|||
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-10ug |
|||
| QP10359-ec-10ug | EnQuireBio | 10ug | EUR 184.8 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-50ug |
|||
| QP10359-ec-50ug | EnQuireBio | 50ug | EUR 348 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-100ug |
|||
| QP10359-ec-100ug | EnQuireBio | 100ug | EUR 630 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-250ug |
|||
| QP10359-ec-250ug | EnQuireBio | 250ug | EUR 1077.6 |
 Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-500ug |
|||
| QP5332-500ug | EnQuireBio | 500ug | EUR 991.2 |
 Biotinylated Human CD40 Ligand / TNFSF5 Protein, Avitag™,Fc Tag |
|||
| CDL-H82F1 | ACROBIOSYSTEMS | 25ug | EUR 1678.6 |
|
Description: Biotinylated Human CD40 Ligand, Avitag,Fc Tag (CDL-H82F1) is expressed from human 293 cells (HEK293). It contains AA Met 113 - Leu 261 (Accession # P29965-1). |
|||
 CLIA Kit) Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) CLIA Kit |
|||
| MBS2532255-5x96Tests | MyBiosource | 5x96Tests | EUR 2565 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) CLIA Kit |
|||
| MBS2532255-96Tests | MyBiosource | 96Tests | EUR 560 |
 CLIA Kit) Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) CLIA Kit |
|||
| abx195380-96tests | Abbexa | 96 tests | EUR 618.75 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) CLIA Kit |
|||
| 20-abx491058 | Abbexa |
|
|
 ELISA Kit) Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-10x96Tests | MyBiosource | 10x96Tests | EUR 4060 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-24Tests | MyBiosource | 24Tests | EUR 265 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-48Test | MyBiosource | 48Test | EUR 450 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-5x96Test | MyBiosource | 5x96Test | EUR 2265 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-96Tests | MyBiosource | 96Tests | EUR 535 |
 Human CellExp? CD40 Ligand / TNFSF5 Protein, Fc Tag, Mouse recombinant |
|||
| P1127-10 | Biovision | each | EUR 170.4 |
Human CellExp? CD40 Ligand / TNFSF5 Protein, Fc Tag, Mouse recombinant |
|||
| P1127-50 | Biovision | each | EUR 574.8 |
 ELISA Kit) Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx050201-96tests | Abbexa | 96 tests | EUR 924 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx151003 | Abbexa |
|
|
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx250223-96tests | Abbexa | 96 tests | EUR 801.6 |
 Biotinylated) Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| MBS2569199-002mg | MyBiosource | 0.02mg | EUR 350 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| MBS2569199-01mg | MyBiosource | 0.1mg | EUR 855 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| MBS2569199-5x01mg | MyBiosource | 5x0.1mg | EUR 3835 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| PKSH034016-100ug | Elabscience Biotech | 100ug | EUR 924 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| PKSH034016-20ug | Elabscience Biotech | 20ug | EUR 342 |
|
Description: Human |
|||
) Human Anti-CD40L (CD40 Ligand, CD154, Tumor Necrosis Factor Ligand Superfamily Member 5, TNFSF5, Gp39, TRAP) |
|||
| MBS6120622-01mg | MyBiosource | 0.1(mg | EUR 650 |
Human Anti-CD40L (CD40 Ligand, CD154, Tumor Necrosis Factor Ligand Superfamily Member 5, TNFSF5, Gp39, TRAP) |
|||
| MBS6120622-5x01mg | MyBiosource | 5x0.1mg | EUR 2785 |
) Human CD40 Ligand / TNFSF5 Protein, Fc Tag, active trimer (MALS verified) |
|||
| CDL-H5269 | ACROBIOSYSTEMS | 100ug | EUR 2932.1 |
|
Description: Human CD40 Ligand, Fc Tag (active trimer) (MALS verified) (CDL-H5269) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
 Human CD40 Ligand/CD40L/TNFSF5 (aa:108-261, His Tag, >95% Pure)) Recombinant (E.coli) Human CD40 Ligand/CD40L/TNFSF5 (aa:108-261, His Tag, >95% Pure) |
|||
| HCD40L-15-N-10 | Alpha Diagnostics | 10 ug | EUR 255.6 |
) Human CD40 Ligand / TNFSF5 Protein, His,Flag Tag, active trimer (MALS verified) |
|||
| CDL-H52Db | ACROBIOSYSTEMS | 100ug | EUR 2801.3 |
|
Description: Human CD40 Ligand, His,Flag Tag (CDL-H52Db) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
Human CD40 Ligand / TNFSF5 Protein, His,Flag Tag, active trimer (MALS verified) |
|||
| CDL-H52Db-100ug | ACROBIOSYSTEMS | 100ug | EUR 381.5 |
|
Description: Human CD40 Ligand, His,Flag Tag (CDL-H52Db) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
Human CD40 Ligand / TNFSF5 Protein, His,Flag Tag, active trimer (MALS verified) |
|||
| CDL-H52Db-1mg | ACROBIOSYSTEMS | 1mg | EUR 2801.3 |
|
Description: Human CD40 Ligand, His,Flag Tag (CDL-H52Db) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
 Mouse CD40 Ligand/TNFSF5 ELISA kit |
|||
| E22-MC042.48 | EnoGene | 48T | EUR 495 |
Mouse CD40 Ligand/TNFSF5 ELISA kit |
|||
| E22-MC042.96 | EnoGene | 96T | EUR 595 |
 TNFSF10 Antibody) Anti-TRAIL (human) TNFSF10 Antibody |
|||
| A00466-2 | BosterBio | 100ul | EUR 384 |
|
Description: Boster Bio Anti-TRAIL (human) TNFSF10 Antibody catalog # A00466-2. Tested in IF, IHC applications. This antibody reacts with Human. |
|||
 Anti Human TNFSF13 Polyclonal Antibody |
|||
| Y054783 | ABM | 100 µl | EUR 575 |
 Human / Rhesus macaque CD40 Ligand / TNFSF5 Protein, Mouse IgG2a Fc Tag, low endotoxin |
|||
| CDL-H5256 | ACROBIOSYSTEMS | 100ug | EUR 2398 |
|
Description: Human / Rhesus macaque CD40 Ligand, Mouse IgG2a Fc Tag, low endotoxin (CDL-H5256) is expressed from human 293 cells (HEK293). It contains AA Met 113 - Leu 261 (Accession # P29965-1). In the region Met 113 - Leu 261, the AA sequence of Human and Rhesus macaque CD40 Ligand are homologus. |
|||
 Mouse CD40 Ligand/TNFSF5 Recombinant Protein |
|||
| PROTP27548 | BosterBio | Regular: 25ug | EUR 350 |
|
Description: Mouse CD40 Ligand/TNFSF5 Recombinant Protein expressed in Baculovirus with His-tag. Sequence domain: 112-260aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
|||
 Recombinant Mouse CD40 Ligand/TNFSF5 Protein |
|||
| RP00792 | Abclonal | 10μg | EUR 138.16 |
 Mouse CD40 Ligand / TNFSF5 Protein, Fc Tag |
|||
| CDL-M526x | ACROBIOSYSTEMS | 1mg | EUR 327 |
|
Description: Mouse CD40 Ligand, Fc Tag (CDL-M526x) is expressed from human 293 cells (HEK293). It contains AA Gly 115 - Leu 260 (Accession # P27548-1). |
|||
 Human Rhesus macaque CD40 Ligand / TNFSF5 Recombinant Protein Mouse IgG Fc Tag Lyophilized |
|||
| IHUMNRSCD40LGTNFSF5RMSIGGFCLY100UG | Innovative research | each | EUR 762 |
|
Description: Human Rhesus macaque CD40 Ligand / TNFSF5 Recombinant Protein Mouse IgG Fc Tag Lyophilized |
|||
 Human Rhesus macaque CD40 Ligand/TNFSF5 Recombinant Protein Mouse IgG Fc Tag Lyophilized |
|||
| MBS8432791-INQUIRE | MyBiosource | INQUIRE | Ask for price |
 Rabbit anti Human TNFSF14:Preservative Free |
|||
| MBS226242-01mg | MyBiosource | 0.1mg | EUR 440 |
Rabbit anti Human TNFSF14:Preservative Free |
|||
| MBS226242-5x01mg | MyBiosource | 5x0.1mg | EUR 1805 |
 Antibody) Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx021416-400l | Abbexa | 400 µl | Ask for price |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx021416-80l | Abbexa | 80 µl | EUR 1225 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx000686-100l | Abbexa | 100 µl | EUR 400 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx000686-20l | Abbexa | 20 µl | EUR 175 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx000686-50l | Abbexa | 50 µl | EUR 275 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx111483-100l | Abbexa | 100 µl | EUR 612.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx128008-100l | Abbexa | 100 µl | EUR 250 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx128008-1ml | Abbexa | 1 ml | EUR 675 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx128008-200l | Abbexa | 200 µl | EUR 312.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx131772-100g | Abbexa | 100 µg | EUR 775 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx131772-20g | Abbexa | 20 µg | EUR 350 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx131772-5g | Abbexa | 5 µg | EUR 275 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx132187-01mg | Abbexa | 0.1 mg | EUR 312.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx132381-01mg | Abbexa | 0.1 mg | EUR 262.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx139272-100l | Abbexa | 100 µl | EUR 275 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx139272-500l | Abbexa | 500 µl | Ask for price |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx139273-100l | Abbexa | 100 µl | EUR 275 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx139273-500l | Abbexa | 500 µl | Ask for price |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx129310-100l | Abbexa | 100 µl | EUR 300 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx129310-1ml | Abbexa | 1 ml | EUR 875 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx129310-200l | Abbexa | 200 µl | EUR 375 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx129465-100l | Abbexa | 100 µl | EUR 262.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx129465-1ml | Abbexa | 1 ml | EUR 687.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx129465-200l | Abbexa | 200 µl | EUR 325 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx103903-100g | Abbexa | 100 µg | EUR 675 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx103903-20g | Abbexa | 20 µg | EUR 250 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx103903-50g | Abbexa | 50 µg | EUR 312.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx103904-100g | Abbexa | 100 µg | EUR 675 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx103904-20g | Abbexa | 20 µg | EUR 250 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx103904-50g | Abbexa | 50 µg | EUR 312.5 |
